Jose P. Leone, MD, director of the program for breast cancer in men at the Dana-Farber Cancer Institute and assistant professor of medicine at Harvard Medical School, shares why patients and providers need to pay more attention to how breast cancer impacts male patients.
More patients and providers need to be aware that breast cancer can happen in men in order to improve treatment and survival rates in this population, according to Jose P. Leone, MD, director of the program for breast cancer in men at the Dana-Farber Cancer Institute and assistant professor of medicine at Harvard Medical School.
Transcript
How has the diagnosis and treatment of men with breast cancer evolved over time, and what more needs to be done to ensure adequate treatment for this population?
Leone: So, breast cancer treatment in men has historically mirrored the treatment for women. And many of those things are actually still being done today. So, for example, the use of tamoxifen as a standard endocrine therapy option in men remains the current standard today. The use of mastectomy initially, and then, the adoption of other possible surgical options, such as lumpectomy in men, has been something that has changed over time also. We look forward to having more data in some of the questions that we have in clinics to move the field forward in the treatment of breast cancer in men and to get data specific for men as compared with women.
What are some of the challenges that are unique to treating men with breast cancer?
Leone: One of the biggest challenges is the lack of data specific for men. Sometimes there are no studies done to answer a particular question. Sometimes the studies are of lower quality than the size that we're used to seeing in women. And that, to me, is one of the biggest challenges in in managing this type of breast cancer.
What do you wish that more oncologists and health care professionals understood about breast cancer in male patients?
Leone: One of the main things for me, personally, I think, is awareness and to be aware that breast cancer can happen in men because early diagnosis of men who present with signs and symptoms of breast cancer is very important given the lack of screening mammograms in this population. So, I would like people to be aware that this can happen and not delay to the workups, which sometimes happens.
Award-Winning Poster Presentations From AMCP 2024
April 23rd 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Read More
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More